Article
Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic…
medRxiv · 2021 · Jeremy D. Kratz
Key facts
| Title | Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity |
|---|---|
| First author | Jeremy D. Kratz |
| Journal | medRxiv |
| Published | Oct 15, 2021 |
| DOI | 10.1101/2021.10.15.464556 |
| Devices mentioned | K981231 |
| Product codes mentioned | JJH, PFF, PFT, PPM, KHS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1